A fully biodegradable polydioxanone occluder for ventricle septal defect closure

[1]  Gaoyang Guo,et al.  Development of Innovative Biomaterials and Devices for the Treatment of Cardiovascular Diseases , 2022, Advanced materials.

[2]  Jinxin Lin,et al.  In vitro and in vivo properties study of a novel 3D-printed absorbable pancreaticojejunostomy device made by melting blended poly(p-dioxanone)/poly(lactic acid) , 2021, Materials & Design.

[3]  Deyuan Zhang,et al.  Surface modification to enhance cell migration on biomaterials and its combination with 3D structural design of occluders to improve interventional treatment of heart diseases. , 2021, Biomaterials.

[4]  Christopher R. Ellis,et al.  Amplatzer Amulet Left Atrial Appendage Occluder Versus Watchman Device for Stroke Prophylaxis (Amulet IDE) , 2021, Circulation.

[5]  Young Jin Kim,et al.  Removed 5-Year-Old Amulet Device: Triplet of Peridevice Leakage, Poor Endothelialization, and Device-Related Thrombus. , 2021, JACC. Cardiovascular interventions.

[6]  Zhiwei Zhang,et al.  Initial Clinical Experience with the Biodegradable AbsnowTM Device for Percutaneous Closure of Atrial Septal Defect: A 3-Year Follow-Up , 2021, Journal of interventional cardiology.

[7]  Deyuan Zhang,et al.  Biodegradable polymeric occluder for closure of atrial septal defect with interventional treatment of cardiovascular disease. , 2021, Biomaterials.

[8]  B. Schmitt,et al.  Carag bioresorbable septal occluder (CBSO): histopathology of experimental implants. , 2018, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[9]  Berto J. Bouma,et al.  Changing Landscape of Congenital Heart Disease , 2017, Circulation research.

[10]  Sheng-Shou Hu,et al.  Perventricular device closure of perimembranous ventricular septal defect: effectiveness of symmetric and asymmetric occluders , 2017, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[11]  David S. Hirsh,et al.  User-reported abrasion-related lead failure is more common with durata compared to other implantable cardiac defibrillator leads. , 2015, Heart rhythm.

[12]  J. Sarasua,et al.  Competing specific interactions investigated by molecular dynamics: analysis of poly(p-dioxanone)/poly(vinylphenol) blends. , 2013, The journal of physical chemistry. B.

[13]  E. Sideris,et al.  Transcatheter patch occlusion of the left atrial appendage using surgical adhesives in high-risk patients with atrial fibrillation. , 2011, Journal of the American College of Cardiology.

[14]  Jin-Hyun Kim,et al.  Tissue-engineered bone formation using periosteal-derived cells and polydioxanone/pluronic F127 scaffold with pre-seeded adipose tissue-derived CD146 positive endothelial-like cells. , 2011, Biomaterials.

[15]  Daniel J Penny,et al.  Ventricular septal defect , 2011, The Lancet.

[16]  A. Zwinderman,et al.  The changing epidemiology of congenital heart disease , 2011, Nature Reviews Cardiology.

[17]  U. Sharma,et al.  The biocompatibility of rapidly degrading polymeric stents in porcine carotid arteries. , 2010, Biomaterials.

[18]  F. Keller,et al.  Biodisk: A new device for closure of patent foramen ovale: A feasibility study in swine , 2010, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[19]  É. Mousseaux,et al.  A polydioxanone electrospun valved patch to replace the right ventricular outflow tract in a growing lamb model. , 2010, Biomaterials.

[20]  Zhi-fei Xu,et al.  Chest wall reconstruction in a canine model using polydioxanone mesh, demineralized bone matrix and bone marrow stromal cells. , 2009, Biomaterials.

[21]  L. Benson,et al.  Late complete heart block in an adult patient undergoing percutaneous ventricular septal defect closure. , 2008, The Journal of invasive cardiology.

[22]  D. Penny,et al.  Transcatheter closure of perimembranous ventricular septal defect , 2007, Heart.

[23]  W. Hillis,et al.  BioSTAR Evaluation STudy (BEST): A Prospective, Multicenter, Phase I Clinical Trial to Evaluate the Feasibility, Efficacy, and Safety of the BioSTAR Bioabsorbable Septal Repair Implant for the Closure of Atrial-Level Shunts , 2006, Circulation.

[24]  P. Wohlsein,et al.  Interventional atrial septal defect closure using a totally bioresorbable occluder matrix: development and preclinical evaluation of the BioSTAR device. , 2006, Journal of the American College of Cardiology.

[25]  Xiu-li Wang,et al.  Thermal properties and non-isothermal crystallization behavior of biodegradable poly(p-dioxanone)/poly(vinyl alcohol) blends , 2006 .

[26]  W. Yip,et al.  Heart block and empirical therapy after transcatheter closure of perimembranous ventricular septal defect , 2005, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[27]  Joel Rosenblatt,et al.  Preparation and physicochemical characterization of biodegradable nerve guides containing the nerve growth agent sabeluzole. , 2005, Biomaterials.

[28]  H. Sievert,et al.  Incidence and clinical course of thrombus formation on atrial septal defect and patient foramen ovale closure devices in 1,000 consecutive patients. , 2004, Journal of the American College of Cardiology.

[29]  Q. Cao,et al.  Early ECG Abnormalities Associated with Transcatheter Closure of Atrial Septal Defects Using the Amplatzer® Septal Occluder , 2000, Journal of Interventional Cardiac Electrophysiology.

[30]  M. Simoons,et al.  Excellent survival and low incidence of arrhythmias, stroke and heart failure long-term after surgical ASD closure at young age. A prospective follow-up study of 21-33 years. , 2003, European heart journal.

[31]  J. Hoffman,et al.  The incidence of congenital heart disease. , 2002, Journal of the American College of Cardiology.

[32]  K. Larntz,et al.  Comparison between transcatheter and surgical closure of secundum atrial septal defect in children and adults: results of a multicenter nonrandomized trial. , 2002, Journal of the American College of Cardiology.

[33]  B. Wunderlich,et al.  Heat capacity of poly-p-dioxanone , 1998 .